NEWS PROVIDED BY Boston Scientific Corporation 08:30 ET MARLBOROUGH, Mass., July 5, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2017 on Thursday, July 27, 2017 at 8:00 a.m. EDT. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan […]
Author: Ken Dropiewski
BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes
NEWS PROVIDED BY BD (Becton, Dickinson and Company) Jul 03, 2017, 06:00 ET FRANKLIN LAKES, N.J., July 3, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that, in connection with its previously announced offers to exchange (the “Exchange Offers”) any and all outstanding 4.400% Notes due 2021, 3.000% Notes due 2026 […]
HeartFlow Announces American Medical Association Issues Unique Category III CPT Codes For HeartFlow FFRct
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that the American Medical Association (AMA) has issued a set of new Category III Current Procedural Terminology (CPT®) codes for HeartFlow® FFRct, a first-of-its-kind noninvasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD). The CPT code application was submitted […]
Sirtex Medical (SRX.AX) Release: New Analysis Reveals First-Line Treatment Data On SIR-Spheres Y-90 Resin Microspheres For Patients With Liver Metastases From Right-Sided Primary Colon Cancer
BARCELONA, Spain, July 3, 2017 /PRNewswire/ — SIRFLOX and FOXFIRE Global findings suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to standard first-line chemotherapy may improve overall survival in metastatic colorectal cancer (mCRC) patients with right-sided primary tumours, compared to those receiving chemotherapy alone. A post-hoc analysis of data from the 739-patient SIRFLOX […]
Edwards Lifesciences (EW)’ INSPIRIS RESILIA Valve Wins FDA Approval
IRVINE, Calif., July 5, 2017/PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received U.S. Food and Drug Administration (FDA) approval for its INSPIRIS RESILIA aortic valve, the first in a new class of resilient heart valves. […]
3-D Printed Models Could Improve Patient Outcomes in Heart Valve Replacements
Article ID: 677120 Released: 27-Jun-2017 11:45 AM EDT Source Newsroom: Georgia Institute of Technology Newswise — Heart valve models created with advanced 3-D printers could soon assist cardiologists in preparing to perform life-saving heart valve replacements. Researchers at Georgia Institute of Technology and the Piedmont Heart Institute are using standard medical imaging and […]
BIOTRONIK US Announces Pivotal Trial Results of the Pulsar-18 Stent with 4-French Delivery System
NEWS PROVIDED BY BIOTRONIK Jul 03, 2017, 10:00 ET LAKE OSWEGO, Ore., July 3, 2017 /PRNewswire/ — BIOTRONIK today announced the results of the BIOFLEX-I clinical study and availability of Pulsar®-18 for the treatment of patients with peripheral artery disease (PAD). Pulsar-18 is the only superficial femoral artery (SFA) self-expanding stent approved by the FDA with […]
ER Overcrowding Impacts Outcomes Disproportionately in African American Communities
By Ken Dropiewski, (Ken@prime-core.com) Researchers recently looked at data from more than 91,000 patients who were admitted to hospitals in California with the diagnosis of a heart attack between the years of 2001 and 2011. The study did not find a meaningful difference in the rates of survival one year […]
Shareholders say “not so fast!” Revive suit against Cardiovascular Systems
Here we go again, shareholders bring lawsuit back to life after recent action… Shareholders revive class-action kickbacks suit against Cardiovascular Systems Shareholders revived a purported class-action kickbacks lawsuit against Cardiovascular Systems (NSDQ:CSII) that was dismissed without prejudice earlier this year, citing in the new complaint a $25 million judgment against the company […]
Philips expands technology leadership in image-guided therapy with acquisition of CardioProlific Inc.
Press Release | June 29, 2017 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced the acquisition of CardioProlific Inc., a US-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial details of the transaction will not be disclosed. […]



